Histopathological Grade Versus Hormone Receptor Status in Breast Carcinoma- Treasure the Past

International Journal of Biomedical Research
doi 10.7439/ijbr.v6i7.2203
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Scholar Science Journals

Related search

Histopathological Grade Versus Estrogen and Progestron Receptor Status in Carcinoma Breast- A Single Center Study

Journal of Medical Science And clinical Research
2017English

Histopathological Grade Versus Estrogen and Progestron Receptor Status in Carcinoma Breast- A Single Center Study

Open Access Journal of Surgery
2017English

Risk of Second Breast Cancers After Lobular Carcinoma in Situ According to Hormone Receptor Status

PLoS ONE
Multidisciplinary
2017English

Correlation of Sonographic Features of Invasive Ductal Mammary Carcinoma With Age, Tumor Grade, and Hormone-Receptor Status

Journal of Clinical Ultrasound
Nuclear MedicineRadiologyImaging
2012English

Study on Histopathological Correlation With ER, PR, and HER 2 Neu Receptor Status in Breast Carcinoma and Its Prognostic Importance

SSR Institute of International Journal of Life Sciences
2019English

Epithelial Proliferation and Hormone Receptor Status in the Normal Post-Menopausal Breast and the Effects of Hormone Replacement Therapy

British Journal of Cancer
Cancer ResearchOncology
1998English

Folate Intake and Risk of Breast Cancer Characterized by Hormone Receptor Status

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2005English

Association Between Contralateral Prophylactic Mastectomy and Breast Cancer Outcomes by Hormone Receptor Status

Cancer
Cancer ResearchOncology
2012English

Expression of Estrogen and Progesterone Receptor Status in Breast Carcinoma Using Quick Score

Annals of Pathology and Laboratory Medicine
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy